NEWS & EVENTS
Listen to an overview of preclinical and clinical applications of our neuroanalytic platforms by our founder,
Dr. Monica Metea
connect with us at conferences
-
BR41N.IO Designers' Hackathon at IEEE SMC 2024
Oct 6-7 2024
-
CNS Summit 2024 in Boston
Nov 10-13 2024
-
American College of Toxicology (2024) in Austin, Texas
45th Annual Meeting: November 17–20, 2024
-
SfN24 - Society for Neuroscience in Chicago
October 5– 9 2024
-
Psych Congress in Boston, MA
October 29 - November 2, 2024
Listen to an introduction to preclinical nerve conduction presented for our collaborators at Altasciences by our founder,
Dr. Monica Metea
RECENT CONFERENCES
-
Society of Toxicology SLC 2024
Invited presentation on ‘Preclinical Nerve Conduction Methods for Assessing the Risk of Gene Therapy-Related Peripheral Neuropathies’
-
Annual World Congress of Society for Brain Mapping and Therapeutics 2024
We presented “Predicting Neurotransmitter Contribution to Drug Effects on Brain Network Function Using qEEG Tomography (qEEGt) in Nonhuman Primates and Humans“
-
2nd Edition of Gene and Cell Therapy @ GCT Virtual
Dr. Metea presented on nerve conduction in juvenile animals for gene therapy-related PN derisking
Join us for networking
and workshops
We organize regular meetings to exchange ideas, learn about latest developments in neuroscience, and brainstorm applications.
Lucerum users meetings
Preclinical EEG-qEEG (pharma)
TMS guidance with qEEG (clinical)
Clinical qEEG discussion group
Neurofeedback focus
Peripheral nervous system e-phyz
1:1 with our team members
SELECTED WORKS
PRESENTATIONS
Metea M., Crum L., Palmero Soler E., Predicting Neurotransmitter Contribution to Drug Effects on Brain Network Function Using EEG Tomography in Nonhuman Primates and Humans. Presentation at Society for Brain Mapping and Therapeutics 2024.
Anantharam P., Burenheide K., Hunziger A., Moore J., Beske P., Metea M., Saporito M. Intravenous Ganaxolone Attenuates Sarin Nerve Agent Induced Seizures. Presented at the American Epilepsy Society Annual Meeting, 2023.
Metea M., A drug development workbench platform for qEEG and multivariate data. Invited talk presented at the Safety Pharmacology Society Conference, 2023
Metea M., Palmero Soler E., Pierce E.B., Gould R.H..Characterization of drugs targeting the mu opioid receptor (MOR) Using Multivariate Quantitative Electroencephalography (qEEG) and Sleep/Wake Metrics. Poster presented at the Safety Pharmacology Society Conference, 2023
Metea M., Palmero Soler E., Holter K.M., Newman A.H, Gould R.H.. Characterization of Novel Selective DAT Inhibitors Using Multivariate qEEG and Sleep/Wake Metrics. Poster presented at the American College of Toxicology Conference, 2023
Rountree C., Metea M., Curley J.L., Terral M., Schmidt E., Moore M.J. Novel neurotoxicity screening platform to examine functional changes in rodent dorsal root ganglia and human iPSC-derived sensory neuron cultures. Poster presented at the Society of Toxicology Conference, 2023
Jahnke M.J., Metea M., Palmero Soler E., Preclinical electrophysiologic nerve conduction assessments of peripheral neuropathies (PN) secondary to administration of AAV-based gene therapies: focus on early detection and severity ranking of sensory PN in primates. Poster presented at the Safety Pharmacology Society Conference, 2023
PUBLICATIONS
Buss N, Lanigan L, Zeller J, et al. Characterization of AAV-mediated dorsal root ganglionopathy. Mol Ther Methods Clin Dev. 2022;24:342-354. doi:10.1016/j.omtm.2022.01.013
Holzer P, Chang EJ, Rogers K, et al. Large-gap peripheral nerve repair using xenogeneic transplants in rhesus macaques. Xenotransplantation. 2023;30(2):e12792. doi:10.1111/xen.12792
Metea M, Palmero-Soler E, Crum L. Preclinical nerve conduction: Nerve battery options for primate studies. J Pharmacol Toxicol Methods. 2022;116:107187. doi:10.1016/j.vascn.2022.107187
Metea, M.R, Center, W., Messenheimer, J., EEG screening process using normative qEEG databases and topographical mapping, J Pharmacol Toxicol Methods 2020, Safety Pharmacology Society conference poster.
Metea M, Lyng GD, Mena JD. Nerve conduction assessments detect early changes in sensory and motor nerve function in a preclinical mouse model of chemotherapy-induced peripheral neuropathy (CIPN). Journal of Pharmacological and Toxicological Methods. 2019;99:106595. doi:10.1016/j.vascn.2019.05.079
Kearney KR, Jenkins CJ, Adkins NA, et al. Surface lead EEGs: Will it stick? Journal of Pharmacological and Toxicological Methods. 2019;99:106595. doi:10.1016/j.vascn.2019.05.071
Metea MR, Appleby C, Kearney K. Characterization of alfaxalone-induced seizures in dogs upon emergence from anesthesia. Journal of Pharmacological and Toxicological Methods. 2018;93:135. doi:10.1016/j.vascn.2018.01.451
Bradley J, Metea M, Strock CJ. Evaluating the pharmacology and neurotoxic predictability of neuroactive compounds using human induced pluripotent stem cell-derived glutamatergic neurons co-cultured with astrocytes using a microelectrode array platform. Journal of Pharmacological and Toxicological Methods. 2018;93:136-137. doi:10.1016/j.vascn.2018.01.456
Bradley JA, Luithardt HH, Metea MR, Strock CJ. In Vitro Screening for Seizure Liability Using Microelectrode Array Technology. Toxicological Sciences. 2018;163(1):240-253. doi:10.1093/toxsci/kfy029
Metea M, Litwak M, Arezzo J. Assessment of seizure risk in pre-clinical studies: Strengths and limitations of the electroencephalogram (EEG). Journal of Pharmacological and Toxicological Methods. 2015;75:135-142. doi:10.1016/j.vascn.2015.04.001
Metea M. Advantages and limitations of computerized methods for analysis of telemetry EEG data. Journal of Pharmacological and Toxicological Methods. 2015;75:162. doi:10.1016/j.vascn.2015.08.016
Gill R, Wakefield A, McPherson H, Piontek M, Best D, Gould K. Assessment of radio telemetry signal quality during blood sampling from the arterial or venous circulation in nonhuman primates. Journal of Pharmacological and Toxicological Methods. 2013;68(1):e17-e18. doi:10.1016/j.vascn.2013.01.070
Metea MR, Gleason TR, Atterson PR. Correlation between respiratory minute volumes and blood gas values in artificially-ventilated beagle dogs. Journal of Pharmacological and Toxicological Methods. 2012;66(2):196-197. doi:10.1016/j.vascn.2012.08.134
Metea MR, Gleason TR, Atterson PR. Cardiovascular and video-electroencephalogram (EEG) telemetry collection in freely moving beagle dogs—A qualification study. Journal of Pharmacological and Toxicological Methods. 2012;66(2):187. doi:10.1016/j.vascn.2012.08.101
Metea MR, Vidmar TJ, Shellhammer LJ, Atterson PR. Exploring filtering and correction factors in a standard dog cardiovascular model. Journal of Pharmacological and Toxicological Methods. 2011;64(1):e38. doi:10.1016/j.vascn.2011.03.135
Metea MR, Setzer JJ, Vidmar TJ, Shellhammer LJ, Atterson PR. Correlation between an external and an implanted telemetry system in conscious non-human primates. Journal of Pharmacological and Toxicological Methods. 2011;64(1):e43-e44. doi:10.1016/j.vascn.2011.03.152
Kearney K, Metea M, Gleason T, Edwards T, Atterson P. Evaluation of respiratory function in freely moving Beagle dogs using implanted impedance technology. J Pharmacol Toxicol Methods. 2010;62(2):119-126. doi:10.1016/j.vascn.2010.06.004
Metea MR, Newman EA. Signalling within the neurovascular unit in the mammalian retina. Exp Physiol. 2007;92(4):635-640. doi:10.1113/expphysiol.2006.036376
Metea MR, Kofuji P, Newman EA. Neurovascular coupling is not mediated by potassium siphoning from glial cells. J Neurosci. 2007;27(10):2468-2471. doi:10.1523/jneurosci.3204-06.2007
Metea MR, Newman EA. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J Neurosci. 2006;26(11):2862-2870. doi:10.1523/JNEUROSCI.4048-05.2006
Metea MR, Newman EA. Calcium signaling in specialized glial cells. Glia. 2006;54(7):650-655. doi:10.1002/glia.20352